![Derek Yoon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Derek Yoon
Directeur Général chez
Solasta Ventures, Inc.
Profil
Derek Yoon currently works at Solasta Ventures, Inc., as President & CEO from 2019, Carbon Biosciences, Inc., as Director, Aju IB Investment Co., Ltd. (Private Equity), as Analyst, and Aju IB Investment US, as Partner.
Mr. Yoon also formerly worked at Clearside Biomedical, Inc., as Independent Director from 2015 to 2017, Trefoil Therapeutics, Inc., as Director from 2015 to 2017, Arcellx, Inc., as Independent Director from 2020 to 2024, Citizens Bank, NA (Providence, Rhode Island), as Portfolio Manager-Healthcare Banking from 2011 to 2013, and Berwind LLC (Massachusetts), as Investment Manager from 2009 to 2011.
Mr. Yoon received his Masters Business Admin degree in 2009 from Babson College, graduate degree in 2011 from Boston College, and undergraduate degree in 1999 from Yonsei University.
Postes actifs de Derek Yoon
| Sociétés | Poste | Début |
|---|---|---|
Aju IB Investment US | Corporate Officer/Principal | - |
Solasta Ventures, Inc.
 Solasta Ventures, Inc. Investment ManagersFinance Solasta Ventures invests in companies located in the United States. The firm focuses on information technology, life sciences, therapeutics, pharmaceutical and biotechnology-based sectors. It participates in early-stage capital requirements. | Directeur Général | 01/07/2019 |
Aju IB Investment Co., Ltd. (Private Equity)
 Aju IB Investment Co., Ltd. (Private Equity) Investment ManagersFinance Aju IB is a long-term investor focused on high technology Korean companies with significant growth potential. Aju IB's investment criteria include management's capability, ethics and transparency, potential market leadership or ability to control the market, technological barriers to entry, significant market size, profitability and maturity. They also take into consideration portfolio diversification. | Analyste en capital-investissement | - |
Carbon Biosciences, Inc.
 Carbon Biosciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops genetic medicines for the treatment of devastating diseases | Directeur/Membre du Conseil | - |
Anciens postes connus de Derek Yoon
| Sociétés | Poste | Fin |
|---|---|---|
| ARCELLX, INC. | Directeur/Membre du Conseil | 18/03/2024 |
| CLEARSIDE BIOMEDICAL | Directeur/Membre du Conseil | 08/08/2017 |
Trefoil Therapeutics, Inc.
 Trefoil Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company which focuses on the application of novel engineered FGF-1 compounds to treat corneal diseases | Directeur/Membre du Conseil | 01/08/2017 |
Citizens Bank, NA (Providence, Rhode Island)
 Citizens Bank, NA (Providence, Rhode Island) Major BanksFinance Provides commercial banking services | Corporate Officer/Principal | 01/12/2013 |
Berwind LLC (Massachusetts)
 Berwind LLC (Massachusetts) Investment ManagersFinance Berwind invests in companies located in the United States. The firm focuses on a broad range of sectors and industries. It provides financing for early and later stage capital requirements. | Directeur en chef des Investissements | 01/04/2011 |
Formation de Derek Yoon
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
88
Relations au 1er degré
12
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
Babson College
 Babson College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boston College
 Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yonsei University
 Yonsei University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aju IB Investment Co., Ltd. (Private Equity)
Aju IB Investment Co., Ltd. (Private Equity) Investment ManagersFinance Aju IB is a long-term investor focused on high technology Korean companies with significant growth potential. Aju IB's investment criteria include management's capability, ethics and transparency, potential market leadership or ability to control the market, technological barriers to entry, significant market size, profitability and maturity. They also take into consideration portfolio diversification. | Finance |
Citizens Bank, NA (Providence, Rhode Island)
Citizens Bank, NA (Providence, Rhode Island) Major BanksFinance Provides commercial banking services | Finance |
Clearside Biomedical, Inc.
 Clearside Biomedical, Inc. Pharmaceuticals: MajorHealth Technology Manufactures suprachoroidal space injections for eye diseases | Health Technology |
Berwind LLC (Massachusetts)
Berwind LLC (Massachusetts) Investment ManagersFinance Berwind invests in companies located in the United States. The firm focuses on a broad range of sectors and industries. It provides financing for early and later stage capital requirements. | Finance |
Arcellx, Inc.
 Arcellx, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company reimagining cell therapy through the development of innovative immunotherapies | Health Technology |
Aju IB Investment US | |
Trefoil Therapeutics, Inc.
Trefoil Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company which focuses on the application of novel engineered FGF-1 compounds to treat corneal diseases | Health Technology |
Solasta Ventures, Inc.
Solasta Ventures, Inc. Investment ManagersFinance Solasta Ventures invests in companies located in the United States. The firm focuses on information technology, life sciences, therapeutics, pharmaceutical and biotechnology-based sectors. It participates in early-stage capital requirements. | Finance |
Carbon Biosciences, Inc.
Carbon Biosciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops genetic medicines for the treatment of devastating diseases | Health Technology |
Choisissez Zonebourse 
